KDR and neoplasm: In the tumour microenvironment, VEGF secreted by hypoxic tumour cells is a key driver of vasculogenesis initiation by mobilising high-expressing vascular endothelial growth factor receptor 2 (VEGFR2) EPCs from bone marrow [172].